Grant: Alliance Grants
Ryerson University
$50,000.00
COVID-19-Design, rapid prototyping, and certifying a reusable N95 mask_x000d_ _x000d_ _x000d_ _x000d_ _x000d_
EF 2020-21
Résumé
Due to the coronavirus pandemic (COVID-19), hospitals in Canada and around the world have faced a shortage of disposable N95 masks. Besides the immediate desperate need of facemasks, hospitals will encounter waste management challenges of N95 masks in the long term. This project aims at addressing these two challenges by designing, manufacturing and certifying reusable N95 masks to combat COVID-19. A mask solution that can be reused will be proposed and the optimum filtration method will be selected by the help of the partner organization, APC Filtration Inc. Reusable masks will be manufactured and tested to acquire National Institute for Occupational Safety and Health (NIOSH) certification. In addition, materials performance tests as per Health Canada requirements will be completed. A sterilization process for the reusable mask structure will be proposed and its impact on the structure will be investigated. The certified design per NIOSH will be used for designing and manufacturing a cast for high volume injection molding of 1000-5000 parts/day for a total of 500,000 parts. The work with our highly qualified team from Ryerson and APC Filtration Inc. will result in an innovative product that will help in the fight against the COVID-19 pandemic in Canada and worldwide.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
549879-2020
Name nom
Fayazbakhsh, Kazem
Department département
Aerospace Engineering
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
50000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
1702
Research subject group en
Design and manufacturing
Research subject group fr
Conception et fabrication
Research subject en
Advanced manufacturing
Research subject fr
Méthodes de fabrication avancées
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
COVID-19-Design, rapid prototyping, and certifying a reusable N95 mask_x000d_
_x000d_
_x000d_
_x000d_
_x000d_
Keyword
NSERC
Application summary
Due to the coronavirus pandemic (COVID-19), hospitals in Canada and around the world have faced a shortage of disposable N95 masks. Besides the immediate desperate need of facemasks, hospitals will encounter waste management challenges of N95 masks in the long term. This project aims at addressing these two challenges by designing, manufacturing and certifying reusable N95 masks to combat COVID-19. A mask solution that can be reused will be proposed and the optimum filtration method will be selected by the help of the partner organization, APC Filtration Inc. Reusable masks will be manufactured and tested to acquire National Institute for Occupational Safety and Health (NIOSH) certification. In addition, materials performance tests as per Health Canada requirements will be completed. A sterilization process for the reusable mask structure will be proposed and its impact on the structure will be investigated. The certified design per NIOSH will be used for designing and manufacturing a cast for high volume injection molding of 1000-5000 parts/day for a total of 500,000 parts. The work with our highly qualified team from Ryerson and APC Filtration Inc. will result in an innovative product that will help in the fight against the COVID-19 pandemic in Canada and worldwide.
